CN107913370A - 一种中西医结合治疗酒精性肝病的药物及制备方法 - Google Patents
一种中西医结合治疗酒精性肝病的药物及制备方法 Download PDFInfo
- Publication number
- CN107913370A CN107913370A CN201710269604.XA CN201710269604A CN107913370A CN 107913370 A CN107913370 A CN 107913370A CN 201710269604 A CN201710269604 A CN 201710269604A CN 107913370 A CN107913370 A CN 107913370A
- Authority
- CN
- China
- Prior art keywords
- chinese
- root
- traditional chinese
- western
- western medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 208000022309 Alcoholic Liver disease Diseases 0.000 title claims abstract description 34
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 45
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 31
- SEBFKMXJBCUCAI-WAABAYLZSA-N (2r,3r)-3,5,7-trihydroxy-2-[(2s,3s)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-WAABAYLZSA-N 0.000 claims abstract description 24
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 244000298715 Actinidia chinensis Species 0.000 claims abstract description 17
- 235000009434 Actinidia chinensis Nutrition 0.000 claims abstract description 17
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims abstract description 17
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 17
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 17
- 241000723221 Crepis Species 0.000 claims abstract description 17
- 241000196324 Embryophyta Species 0.000 claims abstract description 17
- 235000014066 European mistletoe Nutrition 0.000 claims abstract description 17
- 240000002390 Pandanus odoratissimus Species 0.000 claims abstract description 17
- 235000005311 Pandanus odoratissimus Nutrition 0.000 claims abstract description 17
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 17
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 17
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims abstract description 17
- 241001671201 Tetracera Species 0.000 claims abstract description 17
- 241001123263 Zostera Species 0.000 claims abstract description 17
- 239000011425 bamboo Substances 0.000 claims abstract description 17
- 235000021028 berry Nutrition 0.000 claims abstract description 17
- GPRXGEKBQVXWAQ-UHFFFAOYSA-L disodium;3-[18-(2-carboxylatoethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoate Chemical compound [Na+].[Na+].N1C(C=C2C(=C(C)C(=CC=3C(C)=C(CCC([O-])=O)C(N=3)=C3)N2)C=C)=C(C)C(C=C)=C1C=C1C(C)=C(CCC([O-])=O)C3=N1 GPRXGEKBQVXWAQ-UHFFFAOYSA-L 0.000 claims abstract description 16
- 240000003152 Rhus chinensis Species 0.000 claims abstract description 14
- 235000014220 Rhus chinensis Nutrition 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 241001330002 Bambuseae Species 0.000 claims description 16
- 241000221012 Viscum Species 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 3
- 238000004042 decolorization Methods 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims 3
- 235000015099 wheat brans Nutrition 0.000 claims 3
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 27
- 208000002193 Pain Diseases 0.000 abstract description 14
- 210000003734 kidney Anatomy 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 10
- 241000411851 herbal medicine Species 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 8
- 230000008961 swelling Effects 0.000 abstract description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 6
- 238000011049 filling Methods 0.000 abstract description 6
- 210000000988 bone and bone Anatomy 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 5
- 210000003205 muscle Anatomy 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 229930003427 Vitamin E Natural products 0.000 abstract description 3
- 230000002079 cooperative effect Effects 0.000 abstract description 3
- 230000000857 drug effect Effects 0.000 abstract description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 3
- 235000019165 vitamin E Nutrition 0.000 abstract description 3
- 229940046009 vitamin E Drugs 0.000 abstract description 3
- 239000011709 vitamin E Substances 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 244000152640 Rhipsalis cassutha Species 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 206010023126 Jaundice Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000001848 dysentery Diseases 0.000 description 7
- 208000034189 Sclerosis Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 230000002440 hepatic effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 208000019423 liver disease Diseases 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 208000007848 Alcoholism Diseases 0.000 description 4
- 208000015817 Infant Nutrition disease Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 208000014617 hemorrhoid Diseases 0.000 description 4
- 231100000283 hepatitis Toxicity 0.000 description 4
- 206010036067 polydipsia Diseases 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 201000007930 alcohol dependence Diseases 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 230000004596 appetite loss Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 206010019847 hepatosplenomegaly Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 208000019017 loss of appetite Diseases 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 208000034656 Contusions Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019663 Hepatic failure Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 208000019395 Lactation disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010061481 Renal injury Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010042576 Suppressed lactation Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000013810 inherited porphyria Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 208000007903 liver failure Diseases 0.000 description 2
- 231100000835 liver failure Toxicity 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003402 Arthropod sting Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 101100276976 Drosophila melanogaster Drak gene Proteins 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000006504 Scorpion Stings Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241001441726 Tetraodontiformes Species 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940124344 antianaemic agent Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000915 fish venom Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000005086 glomerual capillary Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 231100000731 ichthyotoxin Toxicity 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 208000018962 mouth sore Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种中西医结合治疗酒精性肝病的药物及制备方法,制成所述中西药组合物有效成分的原料组成为:鸡屎藤、锡叶藤、苞叶木、猕猴桃、赛葵、槲寄生、橹罟子、盐麸子、苦竹叶、芦根、奶浆参、山苦草、白首乌、水飞蓟宾、原卟啉钠;本发明通过将具有消肿止痛、补肝肾、强筋骨、清热解毒等作用的中草药进行结合,进而达到协同增效的作用,使得酒精性肝病患者得到合理调理和治疗;并且结合水飞蓟宾和维生素E这2种西药,进而增强了组合物的保肝、护肝、养肝功效;尤其是结合对原料成分中的用量进行限定和控制,使得各原料成分之间发生相互的协同功效,增强了组合物的药效,使得对酒精性肝病的治疗效果更佳明显。
Description
技术领域
本发明涉及医药技术领域,特别涉及一种中西医结合治疗酒精性肝病的药物及制备方法。
背景技术
酒精性肝病是长期酗酒所致酒精中毒性肝脏疾病,包括脂肪肝、酒精性肝类和酒精性肝硬化。本病在西方国家多见,80%-90%的肝硬化病因是由饮酒所引起。在我国对肝炎后引起的肝硬化比较重视,对酒精性肝硬化认为少见而重视不够。随着我国酒的消耗量增加,临床所见酒精性肝病有逐年增多的趋势。值得今后注意。
酒精性肝病是由于长期大量饮酒导致的肝脏疾病。初期通常表现为脂肪肝,进而可发展成酒精性肝炎、肝纤维化和肝硬化。其主要临床特征是恶心、呕吐、黄疸、可有肝脏肿大和压痛。并可并发肝功能衰竭和上消化道出血等。严重酗酒时可诱发广泛肝细胞坏死,甚至肝功能衰竭。酒精性肝病是我国常见的肝脏疾病之一,严重危害人民健康。近年来酒精性肝病占同期肝病住院患者的比例在不断上升,从1991年的4.2%增至1996年的21.3%;酒精性肝硬化在肝硬化的病因构成比从1999年的10.8%上升到2003年的24.0%。
近年来,将中、西药应用于治疗酒精性肝病的药理和机理的研究开始受到国内学者的关注和重视,研制一种疗效确切、方便实用的治疗酒精性肝病的药物正在成为必然。
发明内容
本发明提供了一种中西医结合治疗酒精性肝病的药物及制备方法;本发明通过将具有消肿止痛、补肝肾、强筋骨、清热解毒等作用的中草药进行结合,进而达到协同增效的作用,使得酒精性肝病患者得到合理调理和治疗;并且结合水飞
蓟宾和维生素E这2种西药,进而增强了组合物的保肝、护肝、养肝功效;尤其是结合对原料成分中的用量进行限定和控制,使得各原料成分之间发生相互的协同功效,增强了组合物的药效,使得对酒精性肝病的治疗效果更佳明显。
为实现上述目的,本发明的技术方案实施如下:
一种中西医结合治疗酒精性肝病的药物,制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:鸡屎藤46-58g、锡叶藤41-54g、苞叶木41-54g、猕猴桃36-50g、赛葵33-46g、槲寄生27-39g、橹罟子27-39g、盐麸子21-33g、苦竹叶15-27g、芦根11-23g、奶浆参11-23g、山苦草6-18g、白首乌6-18g;所述西药组分由以下重量数的原料配制而成:水飞蓟宾0.3-0.7g、原卟啉钠0.1-0.2g。
制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:鸡屎藤55g、锡叶藤51g、苞叶木51g、猕猴桃46g、赛葵42g、槲寄生36g、橹罟子36g、盐麸子30g、苦竹叶24g、芦根20g、奶浆参20g、山苦草15g、白首乌15g;所述西药组分由以下重量数的原料配制而成:水飞蓟宾0.6g、原卟啉钠0.17g。
制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:鸡屎藤52g、锡叶藤48g、苞叶木48g、猕猴桃42g、赛葵39g、槲寄生33g、橹罟子33g、盐麸子27g、苦竹叶21g、芦根17g、奶浆参17g、山苦草12g、白首乌12g;所述西药组分由以下重量数的原料配制而成:水飞蓟宾0.5g、原卟啉钠0.15g。
制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:鸡屎藤49g、锡叶藤45g、苞叶木45g、猕猴桃38g、赛葵36g、槲寄生30g、橹罟子30g、盐麸子24g、苦竹叶18g、芦根14g、奶浆参14g、山苦草9g、白首乌9g;所述西药组分由以下重量数的原料配制而成:水飞蓟宾0.4g、原卟啉钠0.13g。
一种中西医结合治疗酒精性肝病的药物的制备方法,包括以下工艺步骤:
(1)将鸡屎藤和橹罟子加10倍量体积浓度70%乙醇提取三次,每次3小时,滤过,合并滤液,放置过夜,回收乙醇并浓缩至60℃相对密度为1.12-1.15的浓液备用;
(2)将锡叶藤、苞叶木、赛葵、盐麸子、苦竹叶、芦根、奶浆参、山苦草和白首乌放入容器中,首先加入10-15倍量蒸馏水浸泡4-5小时后,加热煮沸3-4小时,提取;第二次加8-10倍量蒸馏水加热煮沸2-3小时,提取;第三次加6-8倍量蒸馏水加热煮沸1-2小时,提取;合并提取液,滤过,得滤液备用;
(3)将猕猴桃和槲寄生入榨机榨出汁液,冷藏,过滤,除去杂质和沉淀,脱色处理,浓缩至含水量为50-55%,再加入0.2-0.3%的抗氧化剂,得药液,备用;
(4)将水飞蓟宾研末,过280目的细粉,备用;
(5)将原卟啉钠溶解于5倍量纯净水中,得溶液备用;
(6)将上述所得的浓液、滤液、药液、细粉和溶液混合,加入糊精搅拌均匀,γ射线照射灭菌,按常规方法制成0.4g/片的片剂,密封包装,即为所述的中西医结合治疗酒精性肝病的药物。
本发明所用中药的药性如下:
鸡屎藤:味甘、酸,性平;归心、肝、脾、肾经。祛风除湿,消食化积,解毒消肿,活血止痛。主治风湿痹痛,食积腹胀,小儿疳积,腹泻,痢疾,中暑,黄疸,肝炎,肝脾肿大,咳嗽,瘰疬,肠痈,无名肿毒,脚湿肿烂,烫火伤,湿疹,皮炎,跌打损伤,蛇蛟蝎螫。《上海常用中草药》载:“祛风,活血,止痛,消肿。治风湿酸痛,跌打损伤,肝脾肿大,无名肿毒。”
锡叶藤:味酸、涩,性平;归肝、大肠经。收涩固脱,消肿止痛。主久泻久痢,便血,脱肛,遗精,白带,子宫脱垂,跌打肿痛。广州部队《常用中草药手朋》载:“收敛,止泻,固精。治肠炎腹泻,肝脾肿大,遗精。”
苞叶木:味淡,性平。利胆退黄。主治黄疸型肝炎,肝硬化腹水。
猕猴桃:味甘、酸,性寒;归肾、胃、胆、脾经。解热,止渴,健胃,通淋。主烦热,消渴,肺热干咳,消化不良,湿热黄疸,石淋,痔疮。崔禹锡《食经》
载:“和中安肝。主疸疸,消渴。”
赛葵:味微甘,性凉;归肺、肝、大肠经。清热利湿,解毒消肿。主湿热泻痢,黄疸,肺热咳嗽,咽喉肿痛,痔疮,痈肿疮毒,跌打损伤,前裂腺炎。《广西中草药》载:“清热利湿,去瘀消肿。治黄疸,痢疾,疟疾,小儿食滞,肺热咳嗽,喉头炎,疮疖,跌打肿痛。”
槲寄生:味苦、甘,性平;归肝、肾经。治补肝肾,强筋骨,祛风湿,安胎。主腰膝酸痛,风湿痹痛,胎动不安,胎漏下血。
橹罟子:味辛、淡,性凉;归肾、脾、肝、胃经。补脾益血,行气止痛,化痰利湿,明目。主痢疾,胃痛,咳嗽,疝气,睾丸炎,痔疮,小便不利,目生翳障。《纲目拾遗》载:“补脾胃,固元气,制伏亢阳,扶持衰土,壮精神,益血,宽痞,消痰,解酒毒,止酒后发渴,利头目,开心益志。”
盐麸子:味酸、咸,性凉。生津润肺,降火化痰,敛汗止痢。主痰嗽,喉痹,黄疸,盗汗,痢疾,顽癣,痈毒,头风白屑。《开宝本草》载:“除痰饮瘴疟,喉中热结,喉痹,止渴,解酒毒,黄疸,天行寒热,痰嗽,变白,生毛发。”
苦竹叶:味苦,性寒;归心、肝经。清心,利尿明目,解毒。主热病烦渴,失眠,小便短赤,口疮,目痛,失音,烫火伤。《日华子本草》载:“治不睡,止消渴,解酒毒,除烦热发汗,治中风失音。”
芦根:味甘,性寒;归肺、胃、膀胱。清热生津,除烦止呕,利尿,透疹。主热病烦渴,胃热呕吐,肺热咳嗽,肺痈吐脓,热淋,麻疹,解河豚鱼毒。《天宝本草》载:“清心益肾,去目雾,头晕,耳鸣,疮毒,夜梦颠倒,遗精。”
奶浆参:味苦、甘,性温。补益肝肾,健脾利湿。主头晕目眩,腰膝酸软,水肿,带下疳积,缺乳。《云南中草药》载:“补肝肾,益脾增乳。治小儿疳积,贫血,白带,水肿,肝炎,缺乳,跌打损伤,肠风下血。”
山苦草:味苦,性寒。清热解毒,凉血消肿。主慢性肝炎,小便淋痛,口疮,疮疡肿毒,跌打肿痛。
白首乌:味苦,性平;归肝、肾、脾胃经。补肝肾,强筋骨,益精血,健脾
消食,解毒疗疮。主腰膝酸软,阳痿遗精,头晕耳鸣,心悸失眠,食欲不振,小儿疳积,产后乳汁稀少,疮痈肿痛,毒蛇咬伤。《山东中药》载:“为滋养、强壮、补血药,并能收敛精气,乌须黑发。治久病虚弱,贫血,须发早白,慢性风痹,腰膝酸软,性神经衰弱,痔疮,肠出血,阴虚久疟,溃疡久不收口。鲜的并有润肠通便的作用,适用于老人便秘。”
本发明与现有技术相比,具有以下有益效果:
本发明通过将具有消肿止痛、补肝肾、强筋骨、清热解毒等作用的中草药进行结合,进而达到协同增效的作用,使得酒精性肝病患者得到合理调理和治疗;并且结合水飞蓟宾和维生素E这2种西药,进而增强了组合物的保肝、护肝、养肝功效;尤其是结合对原料成分中的用量进行限定和控制,使得各原料成分之间发生相互的协同功效,增强了组合物的药效,使得对酒精性肝病的治疗效果更佳明显。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明中西药组合物有效成分的原料组成及重量为:鸡屎藤56g、锡叶藤52g、苞叶木52g、猕猴桃48g、赛葵44g、槲寄生37g、橹罟子37g、盐麸子31g、苦竹叶25g、芦根21g、奶浆参21g、山苦草17g、白首乌17g、水飞蓟宾0.65g、原卟啉钠0.19g。
本发明中西药组合物的制备方法,包括以下工艺步骤:
(1)将鸡屎藤和橹罟子加10倍量体积浓度70%乙醇提取三次,每次3小时,滤过,合并滤液,放置过夜,回收乙醇并浓缩至60℃相对密度为1.12-1.15的浓液备用;
(2)将锡叶藤、苞叶木、赛葵、盐麸子、苦竹叶、芦根、奶浆参、山苦草和白首乌放入容器中,首先加入10-15倍量蒸馏水浸泡4-5小时后,加热煮沸3-4小时,提取;第二次加8-10倍量蒸馏水加热煮沸2-3小时,提取;第三次加6-8
倍量蒸馏水加热煮沸1-2小时,提取;合并提取液,滤过,得滤液备用;
(3)将猕猴桃和槲寄生入榨机榨出汁液,冷藏,过滤,除去杂质和沉淀,脱色处理,浓缩至含水量为50-55%,再加入0.2-0.3%的抗氧化剂,得药液,备用;
(4)将水飞蓟宾研末,过280目的细粉,备用;
(5)将原卟啉钠溶解于5倍量纯净水中,得溶液备用;
(6)将上述所得的浓液、滤液、药液、细粉和溶液混合,加入糊精搅拌均匀,γ射线照射灭菌,按常规方法制成0.4g/片的片剂,密封包装,即为所述的中西医结合治疗酒精性肝病的药物。
用法用量:口服,每日2次,每次2片(每片0.4g),饭后温开水送服,7天为一疗程,3到5个疗程即可痊愈,病情严重者遵医嘱酌增用量,有遗传性卟啉症家族史者忌用。
实施例2
本发明中西药组合物有效成分的原料组成及重量为:鸡屎藤55g、锡叶藤51g、苞叶木51g、猕猴桃46g、赛葵42g、槲寄生36g、橹罟子36g、盐麸子30g、苦竹叶24g、芦根20g、奶浆参20g、山苦草15g、白首乌15g、水飞蓟宾0.6g、原卟啉钠0.17g。
本实施例中西药组合物制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明中西药组合物有效成分的原料组成及重量为:鸡屎藤52g、锡叶藤48g、苞叶木48g、猕猴桃42g、赛葵39g、槲寄生33g、橹罟子33g、盐麸子27g、苦竹叶21g、芦根17g、奶浆参17g、山苦草12g、白首乌12g、水飞蓟宾0.5g、原卟啉钠0.15g。
本实施例中西药组合物制备方法工艺步骤及用法用量与实施例1相同。
实施例4
本发明中西药组合物有效成分的原料组成及重量为:鸡屎藤49g、锡叶藤45g、苞叶木45g、猕猴桃38g、赛葵36g、槲寄生30g、橹罟子30g、盐麸子24g、
苦竹叶18g、芦根14g、奶浆参14g、山苦草9g、白首乌9g、水飞蓟宾0.4g、原卟啉钠0.13g。
本实施例中西药组合物制备方法工艺步骤及用法用量与实施例1相同。
实验部分(动物急性毒性试验):
1、实验材料:实验动物为健康小鼠,雌雄各半,体重22±2g,每组20只小鼠。实验药物选用本发明中西药组合物、利加隆。实验材料选用ALT测定试剂盒。
2、方法:
实验组:取本发明中西药组合物1片溶解在10ml水中,对小鼠进行灌胃,灌胃容积为10ml/kg,早晚各一次,共5天。
对照组:取利加隆1片溶解在10ml水中,对小鼠进行灌胃,灌胃容积为10ml/kg,早晚各一次,共5天。
空白组:服用相同量的生理盐水,早晚各一次,共5天。
3、检测及检测结果:
(1)、肝脏损伤检测:5天后,小鼠眼眶取血,分离血清。测定血清ALT活性。
结果:利加隆对照组小鼠血清ALT活性明显高于试验组。
讨论:根据以上实验结果可知,与常规药物利加隆相比,本申请中的中西药组合物可极大降低对肝脏损伤程度。
(2)、肾脏损伤检测:光镜检查。
结果:对照组肾组织光镜检查可见肾小球增大,基质增多,肾小球毛细血管基底膜弥漫性增厚,系膜细胞轻度增生。实验组和空白组小鼠肾小球及小管间质未见明显的病理改变。
讨论:根据以上实验结果可知,与常规药物利加隆相比,本申请中的中西药组合物可以极大降低对肾脏的损伤程度。
临床资料:
1、病例选择:
选择酒精性肝病的患者280例临床观察,病人随机分成治疗组和对照组,治疗组140例,男性70例,女性70例,年龄38-72岁,平均年龄53.1岁,病程1-5年;对照组140例,男性70例,女性70例,年龄39-71岁,平均年龄52.7岁,病程1-5年;两组病例的病程、症状轻重程度基本一致,无显著差异,具有可比性。
2、药物选择:
治疗组患者服用本发明中西药组合物,口服,每日2次,每次2片(每片0.4g),饭后温开水送服,7天为一疗程,3到5个疗程即可痊愈,病情严重者遵医嘱酌增用量,有遗传性卟啉症家族史者忌用。
对照组服用利加隆,按说明书用,病情严重者遵医嘱酌增用量。
3、疗效判定:
(1)治愈:右上腹胀痛、食欲不振、乏力、体质量减轻、黄疸等症状消失,身体恢复正常。
(2)有效:上述症状有所缓解。
(3)无效:病症无变化。
4、结果:
以上结果显示,治疗组治愈率和总有效率明显高于对照组。
典型病例举例:
1、赵某,女,70岁,退休干部。患者5前查体查出酒精性肝病,在当地医院治疗后未能根治,后经朋友介绍来我院就诊。给予服用本发明中西药组合物2个疗程,身体状况好转;继续服用本发明中西药组合物2个疗程,身体痊愈,随
访未复发,彻底治愈。
2、童某,男,62岁,务农。患者5年来因酗酒反复出现纳差、乏力,偶伴反酸、上腹部隐痛不适,来我院就诊,确诊为酒精性肝病。给予服用本发明中西药组合物1个疗程,上述症状好转;继续服用本发明中西药组合物3个疗程,身体恢复正常,随访未复发,彻底治愈。
3、辛某,男,60岁,务农。患者4年前查出酒精性肝病,出现右上腹胀痛、食欲不振、乏力、体重减轻等症状,曾服用中药调理,未根治,来我院就诊。给予服用本发明中西药组合物1个疗程,上述症状好转;继续服用本发明中西药组合物2个疗程,上述症状消失,随访未复发,彻底治愈。
4、尚某,男,51岁,经理。患者常陪客户喝酒,酒龄已有20年。1年前出现肚子胀,来我院就诊,经检查确诊为酒精性肝病。给予服用本发明中西药组合物1个疗程,上述症状好转;继续服用本发明中西药组合物2个疗程,上述症状全部消失,身体痊愈,随访未复发,彻底治愈。
5、王某,女,47岁,自由职业。患者在一次朋友聚会上饮酒过多后出现腹痛、乏力,来我院就诊,经检查确诊为轻微酒精性肝病。给予服用本发明中西药组合物1个疗程,上述症状好转;继续服用本发明中西药组合物3个疗程,上述症状全部消失,身体痊愈,随访未复发,彻底治愈。
6、黄某,男,40岁,业务员。患者1年前出现酒精性肝病,一直服用中药进行调理,未根治。后经朋友介绍来我院就诊,经检查确诊为酒精性肝病。给予服用本发明中西药组合物3个疗程,上述症状全部消失,身体恢复正常,随访未复发,彻底治愈。
Claims (5)
1.一种中西医结合治疗酒精性肝病的药物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:鸡屎藤46-58g、锡叶藤41-54g、苞叶木41-54g、猕猴桃36-50g、赛葵33-46g、槲寄生27-39g、橹罟子27-39g、盐麸子21-33g、苦竹叶15-27g、芦根11-23g、奶浆参11-23g、山苦草6-18g、白首乌6-18g;所述西药组分由以下重量数的原料配制而成:水飞蓟宾0.3-0.7g、原卟啉钠0.1-0.2g。
2.根据权利要求1所述的一种中西医结合治疗酒精性肝病的药物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:鸡屎藤55g、锡叶藤51g、苞叶木51g、猕猴桃46g、赛葵42g、槲寄生36g、橹罟子36g、盐麸子30g、苦竹叶24g、芦根20g、奶浆参20g、山苦草15g、白首乌15g;所述西药组分由以下重量数的原料配制而成:水飞蓟宾0.6g、原卟啉钠0.17g。
3.根据权利要求1所述的一种中西医结合治疗酒精性肝病的药物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:鸡屎藤52g、锡叶藤48g、苞叶木48g、猕猴桃42g、赛葵39g、槲寄生33g、橹罟子33g、盐麸子27g、苦竹叶21g、芦根17g、奶浆参17g、山苦草12g、白首乌12g;所述西药组分由以下重量数的原料配制而成:水飞蓟宾0.5g、原卟啉钠0.15g。
4.根据权利要求1所述的一种中西医结合治疗酒精性肝病的药物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:鸡屎藤49g、锡叶藤45g、苞叶木45g、猕猴桃38g、赛葵36g、槲寄生30g、橹罟子30g、盐麸子24g、苦竹叶18g、芦根14g、奶浆参14g、山苦草9g、白首乌9g;所述西药组分由以下重量数的原料配制而成:水飞蓟宾0.4g、原卟啉钠0.13g。
5.一种如权利要求1-4任一项所述的检验科消毒用中西药组合物的制备方法,其特征在于:包括以下步骤:
(1)将鸡屎藤和橹罟子加10倍量体积浓度70%乙醇提取三次,每次3小时,滤过,合并滤液,放置过夜,回收乙醇并浓缩至60℃相对密度为1.12-1.15的浓液备用;
(2)将锡叶藤、苞叶木、赛葵、盐麸子、苦竹叶、芦根、奶浆参、山苦草和白首乌放入容器中,首先加入10-15倍量蒸馏水浸泡4-5小时后,加热煮沸3-4小时,提取;第二次加8-10倍量蒸馏水加热煮沸2-3小时,提取;第三次加6-8倍量蒸馏水加热煮沸1-2小时,提取;合并提取液,滤过,得滤液备用;
(3)将猕猴桃和槲寄生入榨机榨出汁液,冷藏,过滤,除去杂质和沉淀,脱色处理,浓缩至含水量为50-55%,再加入0.2-0.3%的抗氧化剂,得药液,备用;
(4)将水飞蓟宾研末,过280目的细粉,备用;
(5)将原卟啉钠溶解于5倍量纯净水中,得溶液备用;
(6)将上述所得的浓液、滤液、药液、细粉和溶液混合,加入糊精搅拌均匀,γ射线照射灭菌,按常规方法制成0.4g/片的片剂,密封包装,即为所述的中西医结合治疗酒精性肝病的药物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710269604.XA CN107913370A (zh) | 2017-04-24 | 2017-04-24 | 一种中西医结合治疗酒精性肝病的药物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710269604.XA CN107913370A (zh) | 2017-04-24 | 2017-04-24 | 一种中西医结合治疗酒精性肝病的药物及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107913370A true CN107913370A (zh) | 2018-04-17 |
Family
ID=61898755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710269604.XA Withdrawn CN107913370A (zh) | 2017-04-24 | 2017-04-24 | 一种中西医结合治疗酒精性肝病的药物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107913370A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109200071A (zh) * | 2018-10-09 | 2019-01-15 | 昆明理工大学 | 盐肤木果实或其提取物的用途 |
CN110787195A (zh) * | 2019-09-05 | 2020-02-14 | 广西中医药大学 | 锡叶藤及其提取物在制备治疗和/或预防化学性肝损伤药物方面的应用 |
CN110787196A (zh) * | 2019-09-05 | 2020-02-14 | 广西中医药大学 | 锡叶藤及其提取物在制备治疗和/或预防酒精性肝损伤药物方面的应用 |
CN111494564A (zh) * | 2020-04-30 | 2020-08-07 | 江苏中兴药业有限公司 | 一种复合型保肝解酒片的制备方法 |
-
2017
- 2017-04-24 CN CN201710269604.XA patent/CN107913370A/zh not_active Withdrawn
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109200071A (zh) * | 2018-10-09 | 2019-01-15 | 昆明理工大学 | 盐肤木果实或其提取物的用途 |
WO2020073869A1 (zh) * | 2018-10-09 | 2020-04-16 | 昆明理工大学 | 盐肤木果实或其提取物的用途 |
CN110787195A (zh) * | 2019-09-05 | 2020-02-14 | 广西中医药大学 | 锡叶藤及其提取物在制备治疗和/或预防化学性肝损伤药物方面的应用 |
CN110787196A (zh) * | 2019-09-05 | 2020-02-14 | 广西中医药大学 | 锡叶藤及其提取物在制备治疗和/或预防酒精性肝损伤药物方面的应用 |
CN110787196B (zh) * | 2019-09-05 | 2022-03-22 | 广西中医药大学 | 锡叶藤及其提取物在制备治疗和/或预防酒精性肝损伤药物方面的应用 |
CN111494564A (zh) * | 2020-04-30 | 2020-08-07 | 江苏中兴药业有限公司 | 一种复合型保肝解酒片的制备方法 |
CN111494564B (zh) * | 2020-04-30 | 2021-07-27 | 江苏中兴药业有限公司 | 一种复合型保肝解酒片的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN104474471A (zh) | 一种治疗甲状腺的中药组合物 | |
CN107913370A (zh) | 一种中西医结合治疗酒精性肝病的药物及制备方法 | |
CN101869626A (zh) | 中药复方制剂舒阴液及其制备与应用 | |
CN102772781A (zh) | 一种治疗慢性结肠炎的中药制剂及其制备方法 | |
CN102000164A (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN103341127A (zh) | 一种配合血液透析治疗尿毒症的中药及制备方法 | |
CN103893613B (zh) | 一种治疗口腔溃疡的药物及制备方法 | |
CN103432485B (zh) | 一种治疗尿结石的中药制剂及制备方法 | |
CN104547313A (zh) | 一种治疗肺癌、乳腺癌、淋巴癌的药物及制备方法 | |
CN103007145A (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN102641445B (zh) | 一种治疗痢疾的药物及其制备方法 | |
CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
CN105396017A (zh) | 一种治疗脂肪肝的中药制剂及其制备方法 | |
CN105079721A (zh) | 一种治疗骨关节炎的中药组合物及其制备方法 | |
CN103920042A (zh) | 用于治疗热陷营血型病毒性脑膜炎的药物及其制备方法 | |
CN104147277A (zh) | 一种治疗重症肌无力的中药制剂及制备方法 | |
CN103705692B (zh) | 一种治疗急性胃肠炎的中药制剂 | |
CN104491364B (zh) | 一种治疗慢性淋巴细胞性甲状腺炎的药丸及制备方法 | |
CN105963586A (zh) | 一种治疗肺脓肿的药物及其制备方法 | |
CN105833228A (zh) | 一种逆转胃癌耐药性的药物制剂及其用途 | |
CN105998876A (zh) | 一种治疗急性胰腺炎的中药制剂及制备方法 | |
CN105920436A (zh) | 一种用于治疗肺癌的药物制剂及其制备方法 | |
CN105079410A (zh) | 一种治疗婴幼儿湿热型腹泻的药物及其制备方法 | |
CN105031441A (zh) | 一种治疗强直性脊柱炎的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180417 |